Business ❯ Corporate Governance ❯ Investor Relations

Stock Market

Public Companies Securities Securities Fraud Tesla Twitter Ultragenyx Pharmaceutical Share Repurchase Fortinet, Inc. Tesla, Inc. Target Corporation

Primoris Hit With Securities Class Action Over Renewables Cost Overruns

Firms filed suit on July 29, escalating investor pressure on Primoris' management.

Multiple Firms File Securities Lawsuits After GRAIL’s NHS‑Galleri Trial Failed

Verra Mobility Plunges After Avis Ends Major Contract

Plaintiffs File Class Action Over ChampionX Buybacks That Allegedly Hid Schlumberger Offers

Commvault Faces Securities Class Action Over ARR Shortfall

Coty Investors Face Friday Lead-Plaintiff Deadline as Lawsuits Broaden Over Alleged Disclosure Failures

Law Firms Court Globant Investors Ahead of June 23 Lead‑Plaintiff Deadline

Alight Investors Urged to Seek Lead Role in Securities Suit Ahead of May 15 Deadline

Coty Securities Suit Moves Forward as Firms Seek Lead Plaintiff by May 22

Law Firms Urge monday.com Investors to Seek Lead Role in Securities Case Before May 11

Soleno Faces Securities Class Action Over DCCR Safety as Investors Weigh May 5 Lead‑Plaintiff Deadline

Law Firms Seek Ultragenyx Investors to Lead Securities Class Actions After OI Trial Miss

Soleno Hit With Securities Class Action Over Prader‑Willi Drug DCCR

Corcept Investors Pressed to Seek Lead Role in Securities Suit After FDA Rebuff of Relacorilant

Concorde International Investors Face May 18 Deadline in Securities Class Action

Soleno Therapeutics Sued in Federal Securities Class Action Over DCCR Safety Disclosures

Avantor Investors Face Dec. 29 Deadline To Seek Lead Role in Securities Class Action

Lead-Plaintiff Deadline Nears in James Hardie Securities Case Over Alleged Inventory Misstatements

James Hardie Investors Face Dec. 23 Deadline in Securities Class Action Over Alleged Inventory Misstatements

CoreWeave Shares Drop Nearly 30% After Cutting 2025 Revenue Outlook to $5.1 Billion